Application of parp1 inhibitor in preparation of tumor immunotherapy preparation

A technology of immunotherapy and inhibitors, applied in the field of biomedicine, can solve problems such as body side effects and stimulate immune responses

Active Publication Date: 2021-02-26
CARBIOGENE THERAPEUTICS CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

From a mechanism point of view, it can not only directly kill tumors, but is also expected to stimulate the immune response of the human body and enhance the anti-tumor effect; however, the toxic and side effects of the immune cytokine storm induced by the virus are difficult to avoid and will cause side effects to the body, so looking for a A therapy that can simultaneously increase the efficacy and reduce the side effects of the virus is very important

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of parp1 inhibitor in preparation of tumor immunotherapy preparation
  • Application of parp1 inhibitor in preparation of tumor immunotherapy preparation
  • Application of parp1 inhibitor in preparation of tumor immunotherapy preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0019] 1. PARP1 plays an important role in the recruitment of NK cells after virus infection in vivo

[0020] In order to determine whether PARP1 is involved in the migration of NK cells to the site of virus infection, the present invention uses the PARP1 inhibitor-AG14361. While the mice were intraperitoneally infected with VV, the mice were injected with 10 mg / kg of AG14361 into the tail vein, once a day, for 3 consecutive days. Day, 3 days after drug administration and virus infection, observe the percentage of NK cells and the total number of cells in the peritoneal cavity, and evaluate the virus clearance capacity of the peritoneal cavity at the same time. The result is as figure 1 As shown, the experiment found that PARP1 inhibitors can inhibit the migration of peritoneal NK cells and reduce the ability of virus clearance after virus infection.

[0021] 2. PARP1 inhibitor inhibits PCF inflammatory factors and chemokines after virus infection in vivo

[0022] Such as ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of biomedicine, and discloses the application of PARP1 inhibitors in the preparation of tumor immunotherapy preparations. The invention finds that PARP1 inhibitors can enhance the efficacy of tumor immunotherapy and reduce toxic and side effects. Specifically: (1) PARP1 inhibitors can reduce the virus clearance ability and increase the duration of oncolytic virus on tumor cells, thereby improving the anti-tumor ability of oncolytic virus. (2) PARP1 inhibition can significantly reduce the cytokines and chemokines released by macrophages, and reduce the immune cytokine storm induced by oncolytic virus, thereby reducing the toxic side effects of oncolytic virus in tumor immunotherapy. The present invention has far-reaching significance for tumor immunotherapy.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the application of PARP1 inhibitors in the preparation of tumor immunotherapy preparations. Background technique [0002] Tumor immunotherapy has made a series of progress in recent years, among which oncolytic virus is one of the most attractive immunotherapies. Oncolytic virus refers to a type of virus that can effectively infect and destroy cancer cells. When infected cells rupture and die, newly formed virus particles are released and further infect surrounding cancer cells. From a mechanism point of view, it can not only directly kill tumors, but is also expected to stimulate the immune response of the human body and enhance the anti-tumor effect; however, the toxic and side effects of the immune cytokine storm induced by the virus are difficult to avoid and will cause side effects to the body, so looking for a A therapy that can simultaneously increase efficacy and reduce viral ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/5517A61P35/00
CPCA61K31/5517A61P35/00
Inventor 寿旗扬杨文君其他发明人请求不公开姓名
Owner CARBIOGENE THERAPEUTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap